CORC

在结果中检索

CORC

浏览/检索结果: 共35条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer 会议论文
作者:  Fizazi, Karim;  Tran, Namphuong;  Fein, Luis Enrique;  Matsubara, Nobuaki;  Antolin, Alfredo Rodriguez
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer. 会议论文
作者:  Fizazi, Karim;  Namphuong Tran;  Enrique Fein, Luis;  Matsubara, Nobuaki;  Rodriguez Antolin, Alfredo
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): anti-vegf cohort subanalysis 会议论文
作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis. 会议论文
作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): anti-VEGF cohort subanalysis 会议论文
作者:  Morgan, Liza;  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis. 会议论文
作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Identification and validation of an 8-gene expression signature for predicting high-Fuhrman grade renal cell carcinoma. 会议论文
作者:  Han, Chengtao;  Wan, Fangning;  Zhu, Yao;  Xu, Qinghua;  Dai, Bo
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Characteristics of Chinese patients with advanced prostate cancer: A muliticentre, non-interventional, observational, prospective, registry study of docetaxel. 会议论文
作者:  Zhang, Zhigen;  Guo, Jianming;  Sun, Zhongquan;  He, Dalin;  Ma, Lulin
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Characteristics of Chinese patients with advanced prostate cancer: A muliticentre, non-interventional, observational, prospective, registry study of docetaxel. 会议论文
作者:  He, Dalin;  Sun, Zhongquan;  Guo, Jianming;  Zhang, Zhigen;  Shan, Yuxi
收藏  |  浏览/下载：4/0  |  提交时间：2019/11/26
Sorafenib versus sunitinib as first-line treatment in metastatic renal cell carcinoma: Largest multicenter retrospective analysis. 会议论文
作者:  Sheng, Xinan;  Zhang, Hailiang;  Li, Xuesong;  Chi, Zhihong;  He, Zhisong
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/13

©版权所有 ©2017 CSpace - Powered by CSpace